Drugs / ImCOOH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00583895 Comparator | Dec 2007 → Dec 2008 | atopic eczema | Valletta Health B.V. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ImCOOH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00583895 ↗ |
| Known as | imidazole-4-carboxylic acid | “the endogenous compound imidazole-4-carboxylic acid (ImCOOH) administered as a topical cream twice daily for 14 days in patients with atopic dermatitis.” NCT00583895 ↗ |
| Route | Topical | “administered as a topical cream” NCT00583895 ↗ |